ClinicalThought

Share

Program Content

Activities

  • T-DXd: ILD Management
    How I Manage Interstitial Lung Disease Associated With Trastuzumab Deruxtecan in My Patients With HER2-Positive MBC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 10, 2020

    Expires: September 09, 2021

  • FAQ: HER2+ MBC
    Frequently Asked Questions in HER2-Positive Metastatic Breast Cancer Care
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 11, 2020

    Expires: September 10, 2021

Provided by

ProCE Banner

Supporters

Daiichi Sankyo, Inc.